These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
636 related articles for article (PubMed ID: 8059919)
1. Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific. Fallon PG; Doenhoff MJ Am J Trop Med Hyg; 1994 Jul; 51(1):83-8. PubMed ID: 8059919 [TBL] [Abstract][Full Text] [Related]
2. Laboratory induced resistance to praziquantel in experimental schistosomiasis. Ismail MM; Taha SA; Farghaly AM; el-Azony AS J Egypt Soc Parasitol; 1994 Dec; 24(3):685-95. PubMed ID: 7844435 [TBL] [Abstract][Full Text] [Related]
3. Altered response of strain of Schistosoma mansoni to oxamniquine and praziquantel. Bonesso-Sabadini PI; de Souza Dias LC Mem Inst Oswaldo Cruz; 2002 Apr; 97(3):381-5. PubMed ID: 12048569 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the effect of oxamniquine, praziquantel and a combination of both drugs on the intramolluscan phase of Schistosoma mansoni. Mattos AC; Pereira GC; Jannotti-Passos LK; Kusel JR; Coelho PM Acta Trop; 2007 May; 102(2):84-91. PubMed ID: 17498638 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of a method for induction of praziquantel resistance in Schistosoma mansoni. Lotfy WM; Hishmat MG; El Nashar AS; Abu El Einin HM Pharm Biol; 2015 Aug; 53(8):1214-9. PubMed ID: 25609146 [TBL] [Abstract][Full Text] [Related]
6. Response of Schistosoma mansoni isolates having different drug sensitivity to praziquantel over several life cycle passages with and without therapeutic pressure. Sabra AN; Botros SS J Parasitol; 2008 Apr; 94(2):537-41. PubMed ID: 18564758 [TBL] [Abstract][Full Text] [Related]
7. Adult worm tegumental damage and egg-granulomas in praziquantel-resistant and -susceptible Schistosoma mansoni treated in vivo. Liang YS; Coles GC; Dai JR; Zhu YC; Doenhoff MJ J Helminthol; 2002 Dec; 76(4):327-33. PubMed ID: 12498638 [TBL] [Abstract][Full Text] [Related]
8. Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel. Ismail M; Metwally A; Farghaly A; Bruce J; Tao LF; Bennett JL Am J Trop Med Hyg; 1996 Aug; 55(2):214-8. PubMed ID: 8780463 [TBL] [Abstract][Full Text] [Related]
9. Experimental chemotherapy of Schistosoma mansoni with praziquantel and oxamniquine: differential effect of single or combined formulations of drugs on various strains and on both sexes of the parasite. Delgado VS; Suárez DP; Cesari IM; Incani RN Parasitol Res; 1992; 78(8):648-54. PubMed ID: 1480600 [TBL] [Abstract][Full Text] [Related]
10. Resistance to oxamniquine of a Schistosoma mansoni strain isolated from patient submitted to repeated treatments. Coelho PM; Lima e Silva FC; Nogueira-Machado JA Rev Inst Med Trop Sao Paulo; 1997; 39(2):101-6. PubMed ID: 9394523 [TBL] [Abstract][Full Text] [Related]
11. Transcriptomic analysis of reduced sensitivity to praziquantel in Schistosoma mansoni. Sanchez MC; Cupit PM; Bu L; Cunningham C Mol Biochem Parasitol; 2019 Mar; 228():6-15. PubMed ID: 30658180 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of treatment of murine Schistosoma mansoni infections with praziquantel and oxamniquine correlates with infection intensity: role of host antibody. Fallon PG; Hamilton JV; Doenhoff MJ Parasitology; 1995 Jul; 111 ( Pt 1)():59-66. PubMed ID: 7609991 [TBL] [Abstract][Full Text] [Related]
13. Medicinal chemistry of antischistosomal drugs: Praziquantel and oxamniquine. da Silva VBR; Campos BRKL; de Oliveira JF; Decout JL; do Carmo Alves de Lima M Bioorg Med Chem; 2017 Jul; 25(13):3259-3277. PubMed ID: 28495384 [TBL] [Abstract][Full Text] [Related]
15. Scanning electron microscopy of the tegumental surface of in vivo treated Schistosoma mansoni (Saudi Arabian geographical strain) with oxamniquine and praziquantel. Shalaby IM; Banaja AA; Ghandour AM J Egypt Soc Parasitol; 1991 Dec; 21(3):797-810. PubMed ID: 1765693 [TBL] [Abstract][Full Text] [Related]
16. Resistance of Schistosoma mansoni to praziquantel: is there a problem? Doenhoff MJ; Kusel JR; Coles GC; Cioli D Trans R Soc Trop Med Hyg; 2002; 96(5):465-9. PubMed ID: 12474468 [TBL] [Abstract][Full Text] [Related]
17. Resistance to praziquantel, effect of drug pressure and stability test. Ismail MM; Farghaly AM; Dyab AK; Afify HA; el-Shafei MA J Egypt Soc Parasitol; 2002 Aug; 32(2):589-600. PubMed ID: 12214936 [TBL] [Abstract][Full Text] [Related]
18. [Treatment of Schistosomiasis mansoni with a combination oxamniquine and praziquantel. II. Experimental observations during the patent phase]. Campos R; Pinto PL; Amato Neto V; Moreira AA Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(3):111-4. PubMed ID: 2515575 [TBL] [Abstract][Full Text] [Related]
19. Short report: diminished susceptibility to praziquantel in a Senegal isolate of Schistosoma mansoni. Fallon PG; Sturrock RF; Niang AC; Doenhoff MJ Am J Trop Med Hyg; 1995 Jul; 53(1):61-2. PubMed ID: 7625534 [TBL] [Abstract][Full Text] [Related]
20. Oxamniquine, praziquantel and lovastatin association in the experimental Schistosomiasis mansoni. Araújo N; Mattos AC; Sarvel AK; Coelho PM; Katz N Mem Inst Oswaldo Cruz; 2008 Aug; 103(5):450-4. PubMed ID: 18797757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]